|
US20020137890A1
(en)
*
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20060160181A1
(en)
*
|
2000-02-15 |
2006-07-20 |
Amgen Inc. |
Fibroblast Growth Factor-23 molecules and uses thereof
|
|
EP1261638A2
(en)
*
|
2000-03-08 |
2002-12-04 |
Chiron Corporation |
Human fgf-23 gene and gene expression products
|
|
CN100387713C
(zh)
*
|
2000-08-11 |
2008-05-14 |
麒麟医药株式会社 |
调节磷酸代谢,钙代谢,钙化和维生素d代谢的多肽及其编码dna
|
|
US7226749B2
(en)
|
2000-12-05 |
2007-06-05 |
Zahradnik Richard J |
Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
|
|
US6838264B2
(en)
|
2000-12-05 |
2005-01-04 |
Immutopics, Inc. |
Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
|
|
KR20030074678A
(ko)
*
|
2000-12-26 |
2003-09-19 |
추가이 세이야쿠 가부시키가이샤 |
혈중 인농도를 저하시키는 인간 ｆｇｆ２３ 단백질 변이체
|
|
CN1602355A
(zh)
*
|
2001-04-26 |
2005-03-30 |
杰诺瓦有限公司 |
与人成纤维细胞生长因子有关的组合物
|
|
CA2471656C
(en)
|
2001-12-28 |
2012-07-31 |
Kirin Beer Kabushiki Kaisha |
Antibody against fibroblast growth factor-23
|
|
US7094551B2
(en)
|
2002-09-17 |
2006-08-22 |
Zahradnik Richard J |
Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23
|
|
JP5118851B2
(ja)
*
|
2003-11-07 |
2013-01-16 |
ノバルティス アーゲー |
線維芽細胞増殖因子フラグメントの使用
|
|
WO2005108607A1
(en)
*
|
2004-05-09 |
2005-11-17 |
Technion Research & Development Foundation Ltd. |
Compositions and methods for treating disorders associated with abnormal phosphate metabolism
|
|
IL161886A0
(en)
*
|
2004-05-09 |
2005-11-20 |
Technion Res & Dev Foundation |
Development of inducers of udp-n-acetyl-alphad-galactosamine: polypeptide n-acetylgalactosami-nyltransferase 3(ppgantase
|
|
BRPI0612974A2
(pt)
*
|
2005-04-18 |
2010-12-14 |
Clearplay Inc |
produto de programa de computador, sinal de dados de computador incorporado em uma mÍdia de transmissço, mÉtodo para associar uma apresentaÇço de multimÍdia com informaÇÕes de filtro de conteédo e reprodutor de multimÍdia
|
|
KR100760525B1
(ko)
*
|
2006-04-13 |
2007-10-04 |
김재만 |
병원성 미생물의 무증폭 다중 정량 검출킷트 및 검출방법
|
|
US8012694B2
(en)
|
2006-09-14 |
2011-09-06 |
Immutopics, Inc. |
Assay for the detection of phosphorylated PTH
|
|
WO2008089936A1
(en)
*
|
2007-01-22 |
2008-07-31 |
Medizinische Universität Innsbruck |
Novel markers for chronic kidney disease
|
|
US7883705B2
(en)
*
|
2007-02-14 |
2011-02-08 |
Kyowa Hakko Kirin Co., Ltd. |
Anti FGF23 antibody and a pharmaceutical composition comprising the same
|
|
WO2009091556A2
(en)
*
|
2008-01-17 |
2009-07-23 |
The General Hospital Corporation |
Diagnostic methods and kits using fibroblast growth factor-23
|
|
US8420088B2
(en)
|
2008-01-28 |
2013-04-16 |
Novartis Ag |
Methods and compositions using FGF23 fusion polypeptides
|
|
TW200936156A
(en)
|
2008-01-28 |
2009-09-01 |
Novartis Ag |
Methods and compositions using Klotho-FGF fusion polypeptides
|
|
MX2010011959A
(es)
*
|
2008-04-29 |
2010-11-30 |
Novartis Ag |
Metodos para monitorear la modulacion de la actividad de cinasa del receptor del factor de crecimiento de fibroblastos y uso de dichos metodos.
|
|
US8889621B2
(en)
|
2009-10-30 |
2014-11-18 |
New York University |
Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of hypophosphatemia
|
|
US20110195077A1
(en)
|
2010-01-29 |
2011-08-11 |
Novartis Ag |
Methods and compositions using fgf23 fusion ppolypeptides
|
|
JP5865838B2
(ja)
|
2010-08-31 |
2016-02-17 |
協和メデックス株式会社 |
線維芽細胞増殖因子−２３の測定方法及び測定試薬
|
|
WO2012055096A1
(zh)
*
|
2010-10-27 |
2012-05-03 |
温州医学院生物与天然药物开发中心有限公司 |
抗fgf-23抗体的制备方法及用途
|
|
US20140294820A1
(en)
|
2011-06-24 |
2014-10-02 |
University Of Miami |
Fibroblast growth factor receptor inhibition for the treatment of disease
|
|
WO2013006486A2
(en)
|
2011-07-01 |
2013-01-10 |
Ngm Biopharmaceuticals, Inc. |
Compositions, uses and methods for treatment of metabolic disorders and diseases
|
|
WO2013027191A1
(en)
|
2011-08-25 |
2013-02-28 |
Novartis Ag |
Methods and compositions using fgf23 fusion polypeptides
|
|
US9657075B2
(en)
|
2012-06-07 |
2017-05-23 |
New York University |
Chimeric fibroblast growth factor 23 proteins and methods of use
|
|
US9290557B2
(en)
|
2012-11-28 |
2016-03-22 |
Ngm Biopharmaceuticals, Inc. |
Compositions comprising variants and fusions of FGF19 polypeptides
|
|
WO2014085365A2
(en)
|
2012-11-28 |
2014-06-05 |
Ngm Biopharmaceuticals, Inc. |
Compositions and methods for treatment of metabolic disorders and diseases
|
|
US9273107B2
(en)
|
2012-12-27 |
2016-03-01 |
Ngm Biopharmaceuticals, Inc. |
Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
|
|
IL292303A
(en)
|
2012-12-27 |
2022-06-01 |
Ngm Biopharmaceuticals Inc |
Methods for modulating bile acid homeostatsis and treatment of bile acid disorders and disease
|
|
WO2014130659A1
(en)
|
2013-02-22 |
2014-08-28 |
New York University |
Chimeric fibroblast growth factor 23 proteins and methods of use
|
|
WO2015040497A2
(en)
*
|
2013-09-20 |
2015-03-26 |
Lonza Ltd |
Methods for nuclear reprogramming of cells
|
|
SG11201602870YA
(en)
|
2013-10-28 |
2016-05-30 |
Ngm Biopharmaceuticals Inc |
Cancer models and associated methods
|
|
PL3097122T3
(pl)
|
2014-01-24 |
2020-10-19 |
Ngm Biopharmaceuticals, Inc. |
Przeciwciała wiążące domenę 2 beta klotho oraz sposoby ich stosowania
|
|
JP2017517272A
(ja)
|
2014-03-28 |
2017-06-29 |
ニューヨーク・ユニバーシティ |
Ｆｇｆ２３融合タンパク質
|
|
WO2015183890A2
(en)
|
2014-05-28 |
2015-12-03 |
Ngm Biopharmaceuticals, Inc. |
Methods and compositions for the treatment of metabolic disorders and diseases
|
|
EP3845245B1
(en)
|
2014-06-09 |
2025-06-25 |
Ultragenyx Pharmaceutical Inc. |
The effective and efficient control of serum phosphate for optimal bone formation
|
|
WO2015195509A2
(en)
|
2014-06-16 |
2015-12-23 |
Ngm Biopharmaceuticals, Inc. |
Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
|
|
WO2016065106A1
(en)
|
2014-10-23 |
2016-04-28 |
Ngm Biopharmaceuticals, Inc. |
Pharmaceutical compositions comprising peptide variants and methods of use thereof
|
|
WO2016073855A1
(en)
|
2014-11-07 |
2016-05-12 |
Ngm Biopharmaceuticals, Inc. |
Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders
|
|
EP3227319B1
(en)
|
2014-12-04 |
2019-11-27 |
Novartis AG |
Methods and compositions using klotho variant polypeptides
|
|
CN105699664A
(zh)
*
|
2015-04-13 |
2016-06-22 |
陈柏龄 |
Fgf23检测试剂盒及其制备方法
|
|
WO2016210350A1
(en)
*
|
2015-06-25 |
2016-12-29 |
Amyris, Inc. |
Maltose dependent degrons, maltose-responsive promoters, stabilization constructs, and their use in production of non-catabolic compounds
|
|
US10800843B2
(en)
|
2015-07-29 |
2020-10-13 |
Ngm Biopharmaceuticals, Inc. |
Beta klotho-binding proteins
|
|
AU2016353988B2
(en)
|
2015-11-09 |
2019-09-26 |
Ngm Biopharmaceuticals, Inc. |
Methods for treatment of bile acid-related disorders
|
|
WO2018039557A1
(en)
|
2016-08-26 |
2018-03-01 |
Ngm Biopharmaceuticals, Inc. |
Methods of treating fibroblast growth factor 19-mediated cancers and tumors
|
|
CA3058306A1
(en)
*
|
2017-03-28 |
2018-10-04 |
Ajinomoto Co., Inc. |
Additive for undifferentiation maintaining medium
|
|
EP3633373B1
(en)
|
2017-05-31 |
2025-02-19 |
Hitachi Chemical Diagnostics Systems Co., Ltd. |
Measurement method for fibroblast growth factor 23, measurement reagent, and measurement kit
|
|
WO2020047475A1
(en)
*
|
2018-08-30 |
2020-03-05 |
The Uab Research Foundation |
Drug screening for fgf23-fgfr4 inhibitors
|
|
JP2022527790A
(ja)
*
|
2019-03-29 |
2022-06-06 |
アターガ，エルエルシー |
抗ｆｇｆ２３抗体分子
|
|
KR20210153069A
(ko)
*
|
2019-04-19 |
2021-12-16 |
제네똥 |
섬유아세포 성장 인자 23 관련 저인산혈증성 질환의 유전자 요법
|